18F-FDG-PET assessment of early treatment response of articular and extra-articular foci in newly diagnosed rheumatoid arthritis

Hellenic Journal of Nuclear Medicine

Volumn 15, Issue 1, 2012, Pages

  Sarma, Manjit ^a   Vijayant, Vishu ^a   Basu, Sandip ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HYDROQUININE; METHOTREXATE; PREDNISOLONE;

ADULT; CASE REPORT; FEMALE; HUMAN; JOINT SWELLING; LETTER; POSITRON EMISSION TOMOGRAPHY; RHEUMATOID ARTHRITIS; THYROIDITIS; TREATMENT RESPONSE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JOINTS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; SECONDARY PREVENTION; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 84859175898     PISSN: 11081430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. 18F-FDG-PET in infective endocarditis: promising role in difficult diagnosis and treatment monitoring. Hell J Nucl Med 2009; 12(2): 165-7.
2. 18F-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris. Hell J Nucl Med 2009; 12(3): 285-6.
3. Polisson RP, Schoenberg OI, Fischman A et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 819-25.
4. 18F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006; 33(3): 275-80.
5. 18F-FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 2006; 31(7): 386-90. (Pubitemid 44315517)